Dominik Rüttinger

4PUBLICATIONS
47CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene and molecular therapyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 15, 2025
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer.

Franziska Siegel, Stephan Siegel, Kristýna Kotýnková

|Dec 15, 2023
Facts and Hopes on Biomarkers for Successful Early Clinical Immunotherapy Trials: Innovative Patient Enrichment Strategies.

Michael A Cannarile, Vaios Karanikas, Bernhard Reis

|Nov 16, 2021
Preclinical Characterization of a Next-Generation Brain Permeable, Paradox Breaker BRAF Inhibitor.

Jürgen Wichmann, Caroline Rynn, Thomas Friess

|May 16, 2020
The PET-Tracer 89Zr-Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment.

Christoph M Griessinger, Tove Olafsen, Alessandro Mascioni

Pageof 1

Frequent Collaborators

1 joint publications

Jason M Romero

1 joint publications

Daulet Satpayev

1 joint publications

Christina Claus

1 joint publications

Christian Klein